Calendar IRLAB Therapeutics AB

Equities

IRLAB A

SE0012675361

Market Closed - Nasdaq Stockholm 12:00:00 2024-06-10 pm EDT 5-day change 1st Jan Change
13.95 SEK -1.41% Intraday chart for IRLAB Therapeutics AB -10.58% +86.00%

Chart calendar IRLAB Therapeutics AB

7910f378a.iC1yqDMiATQP6C_AIBIVh5XHFBc3qhUbHlow45TSluU.uxg-xUobVFxQsUyZR39v6fmGVXlF8n8sdGt0p_qH4NPpYh7RXhR1cWPdHw~52515e606326a9a713c0402855c04a95

Upcoming events on IRLAB Therapeutics AB

2024-07-10 01:00 am Q2 2024 Earnings Release
2024-10-25 01:00 am Q3 2024 Earnings Release
2024-10-25 04:00 am Q3 2024 Earnings Call
2025-02-14 01:00 am Q4 2024 Earnings Release
2025-05-06 Q1 2025 Earnings Release (Projected)
2025-08-26 Q2 2025 Earnings Release (Projected)
2025-11-04 Q3 2025 Earnings Release (Projected)
2026-02-24 Q4 2025 Earnings Release (Projected)

Past events on IRLAB Therapeutics AB

2024-05-23 04:45 am ABGSC Investor Day
2024-05-22 11:00 am Annual General Meeting
2024-05-08 04:00 am Q1 2024 Earnings Call
2024-05-08 01:20 am Q1 2024 Earnings Release
2024-04-18 12:45 pm Redeye Investor Forum
2024-03-06 Bayes@Lund Conference
2024-03-04 Alzheimer and Parkinson Diseases International Conference
2024-02-07 04:00 am Q4 2023 Earnings Call
2024-02-07 01:00 am Q4 2023 Earnings Release
2023-11-23 08:00 am SEB Healthcare Seminar
2023-11-23 04:00 am Redeye Life Science Day
2023-11-21 ABGSC Investor Day
2023-10-25 BioStock Life Science Fall Summit
2023-10-25 04:00 am Q3 2023 Earnings Call
2023-10-25 01:00 am Q3 2023 Earnings Release
2023-10-24 BioStock Life Science Fall Summit
2023-10-17 08:30 am Capital Markets Day
2023-10-11 04:10 am Redeye Neurology Theme Forum
2023-09-14 09:50 am Pareto Securities' Healthcare Conference
2023-08-30 04:00 am Q2 2023 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK
Released
Forecast
Spread
0,03
0,00
-
0,00


208
206
1.05%
61,1
44,0
38.95%
5,68
7,10
-20.03%

65,7

EBITDA
Million SEK
Released
Forecast
Spread
-92,9
-84,0
-10.62%
0,00


56,1
62,0
-9.63%
-108
-200
45.83%
-176
-183
3.33%

-153

EBIT
Million SEK
Released
Forecast
Spread
-95,8
-86,0
-11.45%
0,00


52,6
58,7
-10.39%
-113
-204
44.55%
-181
-185
2.09%

-110

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-96,1
-86,0
-11.77%
0,00


51,8
58,2
-11.07%
-113
-204
44.41%
-178
-184
3.09%

-160

Net income
Million SEK
Released
Forecast
Spread
-96,1
-86,0
-11.77%
-91,7


51,8
58,2
-11.07%
-113
-204
44.41%
-178
-183
3.08%

-111

EPS
SEK
Released
Forecast
Spread
-2,37
-1,77
-33.9%
-1,92


1,00
1,13
-11.5%
-2,19
-3,85
43.12%
-3,43
-3,55
3.38%

-3,08

Announcement Date06/02/2015/04/2123/02/2223/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales
Million SEK
Released
Forecast
Spread
9,04
11,0
-17.8%
23,4
11,0
112.82%
16,5
11,0
50.03%

11,0

EBITDA
Million SEK
Released
Forecast
Spread
-28,1
-33,0
14.72%
-26,1
-45,0
42.1%
-22,9
-55,0
58.34%

-66,0

EBIT
Million SEK
Released
Forecast
Spread
-29,1
-34,0
14.45%
-27,0
-46,0
41.27%
-23,9
-56,0
57.28%

-67,0

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-29,2
-34,0
14.21%
-27,1
-46,0
41.05%
-24,0
-56,0
57.22%

-67,0

Net income
Million SEK
Released
Forecast
Spread
-29,2
-34,0
14.21%
-27,1
-46,0
41.05%
-24,0
-56,0
57.22%

-67,0

EPS
SEK
Released
Forecast
Spread
-0,56
-0,65
13.85%
-0,52
-0,90
42.22%
-0,46
-1,09
57.8%

-1,19

Announcement Date11/05/2224/08/2209/11/22-

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IRLAB A Stock
  4. Calendar IRLAB Therapeutics AB